Erratum: High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression

Blood Cancer Journal ◽

10.1038/bcj.2017.25 ◽

2017 ◽

Vol 7 (3) ◽

pp. e544-e544 ◽

Author(s):

F Maura ◽

A Guidetti ◽

A Pellegrinelli ◽

A Dodero ◽

M Pennisi ◽

...

Keyword(s):

B Cell ◽

Poor Prognosis ◽

Cell Lymphoma ◽

Autologous Transplantation ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

High Dose ◽

The Poor ◽

Large B Cell Lymphoma ◽

Download Full-text

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression

Blood Cancer Journal ◽

10.1038/bcj.2016.99 ◽

2016 ◽

Vol 6 (11) ◽

pp. e491-e491 ◽

Author(s):

F Maura ◽

A Guidetti ◽

A Pellegrinelli ◽

A Dodero ◽

M Pennisi ◽

...

Keyword(s):

B Cell ◽

Poor Prognosis ◽

Cell Lymphoma ◽

Autologous Transplantation ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

High Dose ◽

The Poor ◽

Large B Cell Lymphoma ◽

Download Full-text

P201 High-dose therapy and autologous transplantation in poor prognosis patients with diffuse large B-cell lymphoma in first remission

Blood Reviews ◽

10.1016/s0268-960x(07)70097-8 ◽

2007 ◽

Vol 21 ◽

pp. S93

Author(s):

T. Papajik ◽

L. Raida ◽

E. Faber ◽

V. Prochazka ◽

J. Vondrakova ◽

...

Keyword(s):

B Cell ◽

Poor Prognosis ◽

Cell Lymphoma ◽

Autologous Transplantation ◽

B Cell Lymphoma ◽

High Dose ◽

High Dose Therapy ◽

Large B Cell Lymphoma ◽

First Remission ◽

Download Full-text

Myelotoxicity and Reduction in Number of CD34 + Early Hematopoietic Progenitors in Adult Poor-Prognosis Patients with Diffuse Large B-Cell Lymphoma in Late Period After High-Dose Chemotherapy by mNHL-BFM-90

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2016.07.178 ◽

2016 ◽

Vol 16 ◽

pp. S121-S122

Author(s):

Elena Dorokhina ◽

Aminat Magomedova ◽

Irina Galtseva ◽

Valentina Dvirnyk ◽

Svetlana Glinkina ◽

...

Keyword(s):

B Cell ◽

Poor Prognosis ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

High Dose ◽

Late Period ◽

Hematopoietic Progenitors ◽

Large B Cell Lymphoma ◽

Download Full-text

RITUXIMAB DOES NOT ADVERSELY AFFECT THE STEM CELL MOBILIZATION AND ENGRAFTMENT AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN FIRST COMPLETE OR PARTIAL REMISSION

Biomedical Papers ◽

10.5507/bp.2009.035 ◽

2009 ◽

Vol 153 (3) ◽

pp. 211-214 ◽

Author(s):

Tomas Papajik ◽

Zuzana Pikalova ◽

Ludek Raida ◽

Ivana Skoumalova ◽

Jana Vondrakova ◽

...

Keyword(s):

Stem Cell ◽

B Cell ◽

Cell Lymphoma ◽

Autologous Transplantation ◽

B Cell Lymphoma ◽

High Dose ◽

High Dose Therapy ◽

Large B Cell Lymphoma ◽

Cell Mobilization ◽

Download Full-text

Front-line High-Dose Chemotherapy with Rituximab Showed Excellent Long-Term Survival in Adults with Aggressive Large B-Cell Lymphoma: Final Results of a Phase II GOELAMS Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2009.12.530 ◽

2010 ◽

Vol 16 (5) ◽

pp. 672-677 ◽

Author(s):

Marie-Sarah Dilhuydy ◽

Thierry Lamy ◽

Charles Foussard ◽

Remy Gressin ◽

Philippe Casassus ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

High Dose ◽

Term Survival ◽

Large B Cell Lymphoma ◽

Download Full-text

Late cardiotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma

Terapevticheskii arkhiv ◽

10.17116/terarkh201587751-57 ◽

2015 ◽

Vol 87 (7) ◽

pp. 51 ◽

Author(s):

E. I. Dorokhina ◽

A. U. Magomedova ◽

A. A. Shevelev ◽

S. M. Kulikov ◽

M. K. Gitis ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

Adult Patients ◽

High Dose ◽

Large B Cell Lymphoma ◽

Late Cardiotoxicity ◽

Download Full-text

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma

Blood Cancer Journal ◽

10.1038/bcj.2015.101 ◽

2015 ◽

Vol 5 (12) ◽

pp. e372-e372 ◽

Author(s):

T Aoki ◽

K Shimada ◽

R Suzuki ◽

K Izutsu ◽

A Tomita ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

B Cell ◽

Autologous Stem Cell Transplantation ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

High Dose ◽

Large B Cell Lymphoma ◽

Download Full-text

Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2016.11.001 ◽

2017 ◽

Vol 17 (3) ◽

pp. 145-151 ◽

Author(s):

Bradley D. Hunter ◽

Megan Herr ◽

Philip J. Meacham ◽

Ferdous Barlaskar ◽

Andrew G. Evans ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

B Cell ◽

Autologous Stem Cell Transplantation ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

High Dose ◽

Large B Cell Lymphoma ◽

Download Full-text

Front-line high-dose chemotherapy (HDT) combined with rituximab for adults with aggressive large B cell lymphoma (DLBCL). A pilot study by the GOELAMS

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6662 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6662-6662 ◽

Author(s):

N. J. Milpied ◽

T. Lamy ◽

P. Casassus ◽

E. Deconninck ◽

R. Gressin ◽

...

Keyword(s):

Pilot Study ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

High Dose ◽

Large B Cell Lymphoma ◽

Download Full-text

Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma

Terapevticheskii arkhiv ◽

10.17116/terarkh201688743-48 ◽

2016 ◽

Vol 88 (7) ◽

pp. 43

Author(s):

E. I. Dorokhina ◽

A. U. Magomedova ◽

V. N. Dvirnyk ◽

I. V. Galtseva ◽

S. A. Glinkina ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose Chemotherapy ◽

Adult Patients ◽

High Dose ◽

Large B Cell Lymphoma ◽

Download Full-text